🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NEW Commentary by Yariana E. Rodríguez Ortiz and @shanebobart #AJKDBlog: The future of #IgAN treatment is multi-targeted and personalized. Is the future now? buff.ly/4c8Cjyh Review by Dawn Caster and R Lafayette: buff.ly/4c8Cjyh

We’re both honored & excited to announce that Houston Methodist Hospital has been named the Best Hospital in Texas by U.S. News & World Report for 13 years in a row.

Kidney Biopsy Findings Among Patients With Diabetes in the Cleveland Clinic Kidney Biopsy Epidemiology Project - Kidney Medicine kidneymedicinejournal.org/article/S2590-… Shane Bobart, MD, FASN 🙌🏼🙌🏼

Grateful for the collaboration Kidney Biopsy Findings Among Patients With Diabetes in the Cleveland Clinic Kidney Biopsy Epidemiology Project - Kidney Medicine kidneymedicinejournal.org/article/S2590-… Alvin Kwon @HannySawaf Gilda Portalatin @DrTariqShafi Cleveland Clinic Kidney Medicine Houston Methodist Nephrology Fellowship Kidney Medicine

American Society of Nephrology Mayo Clinic Nephrology Fun times - Kidney Week 2024 Suzanne Norby Shane Bobart, MD, FASN Khaled Shawwa @SorkkoT

Excellent work by Houston Methodist IM Residency Resident Dr. Robert Jameson American Society of Nephrology #KidneyWk2024 mentored by Houston Methodist Nephrology Fellowship faculty Shane Bobart, MD, FASN and PD Dr. Edwards. Houston Methodist MD

“Define preserved eGFR” Mayo Clinic Nephrology fellowship class of’20

Nephrology fellows and faculty of Houston Methodist Nephrology Fellowship presenting their work American Society of Nephrology #KidneyWk2024 Houston Methodist MD Renuka Tolani Shane Bobart, MD, FASN

Time for a new look at how to manage LN. The old proteinuric centric approach is not enough. In patients with anti-ds-DNA and proliferative LN, targeting immunological remission (negative anti-ds-DNA and normalization of complement) is the key 🔑! kidney-international.org/article/S0085-…

Thank you AJKD #AJKDBlog for this opportunity once again. Grateful to Yariana E. Rodríguez Ortiz and Editor extraordinaire Pascale Khairallah iganfoundation

Our article is out Cleveland Clinic Kidney Medicine Houston Methodist Nephrology Fellowship Nephrology | Karger The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits. karger.com/gdz/article/do…

Big day — our JAMA review on ADPKD is out today! 📢 Grateful to the JAMA editorial team for their partnership in shaping this into a high-impact resource for clinicians. If you manage patients with Polycystic Kidney Disease, we hope you’ll find it valuable.

Excellent review by Fouad Chebib, MD, FASN Mayo Clinic Nephrology PKD Foundation jamanetwork.com/journals/jama/…

Check out our editorial in AJKD @DrTariqShafi

Follistatin, through activin A antagonism, reduces senescence burden, macrophage infiltration, and proinflammatory pathway activation in murine DKD. bit.ly/KID0776 #ASNKidney360 #BasicResearch

GlomCon is thrilled to introduce a new leadership training opportunity 🤩 The Polycystic Kidney Disease Medical Directorship Program (PKD-MDP) is a year-long, interactive program aiming to deepen participants' expertise in PKD diagnosis and management. It also offers a

Excellent work by Tonya Hickson Mayo Clinic Nephrology

LIVERPOOL FOOTBALL CLUB. PREMIER LEAGUE CHAMPIONS.

Check out our editorial in ASN Publications #CJASN on an excellent study by Laurence H Beck, Jr and team. fernando fervenza Mayo Clinic Nephrology

At Mayo, we have long recognized AI as a tool to enhance human expertise. @NYTimes takes a closer look at how our different view has allowed our radiologists to improve accuracy, accelerate diagnosis, and advance cures: nyti.ms/4knWFYj